Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

Rhea-AI Summary

Dynavax Technologies (Nasdaq: DVAX), a commercial stage biopharmaceutical company focused on innovative vaccines, has announced it will report its second quarter 2024 financial results on Tuesday, August 6, 2024, after U.S. financial markets close. The company will host a conference call and live audio webcast on the same day at 4:30 p.m. ET/1:30 p.m. PT.

Investors can access the live audio webcast through the 'Events & Presentations' page on the company's website. A replay will be available for 30 days following the event. To participate in the call, attendees must register using the provided caller registration link. It is recommended that participants join the conference call or webcast approximately 10 minutes before the scheduled start time.

News Market Reaction

+2.28%

1 alert

+2.28% News Effect

On the day this news was published, DVAX gained 2.28%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

EMERYVILLE, Calif., July 23, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2024 financial results on Tuesday, August 6, 2024, after the U.S. financial markets close.

Dynavax will host a conference call and live audio webcast on Tuesday, August 6, 2024, at 4:30 p.m. ET/1:30 p.m. PT.

The live audio webcast may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations. A replay of the webcast will be available for 30 days following the live event.

To dial into the call, participants will need to register for the call using the caller registration link. It is recommended that participants dial into the conference call or log into the webcast approximately 10 minutes prior to the call.

About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, currently focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza and universal influenza. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn and Twitter.

For Investors/Media:
Paul Cox 
pcox@dynavax.com
510-665-0499 

Nicole Arndt
narndt@dynavax.com
510-665-7264

View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-report-second-quarter-2024-financial-results-and-host-conference-call-on-august-6-2024-302204457.html

SOURCE Dynavax Technologies

FAQ

When will Dynavax (DVAX) report its Q2 2024 financial results?

Dynavax (DVAX) will report its second quarter 2024 financial results on Tuesday, August 6, 2024, after the U.S. financial markets close.

What time is Dynavax's (DVAX) Q2 2024 earnings call scheduled for?

Dynavax's (DVAX) Q2 2024 earnings conference call and live audio webcast is scheduled for Tuesday, August 6, 2024, at 4:30 p.m. ET/1:30 p.m. PT.

How can investors access Dynavax's (DVAX) Q2 2024 earnings webcast?

Investors can access Dynavax's (DVAX) Q2 2024 earnings webcast through the 'Events & Presentations' page on the 'Investors' section of the company's website at https://investors.dynavax.com/events-presentations.

How long will the replay of Dynavax's (DVAX) Q2 2024 earnings webcast be available?

The replay of Dynavax's (DVAX) Q2 2024 earnings webcast will be available for 30 days following the live event.